Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Other Working Capital Changes (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Other Working Capital Changes data on record, last reported at -$1.0 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes changed N/A year-over-year to -$1.0 million; the TTM value through Dec 2025 reached $1.0 million, changed N/A, while the annual FY2025 figure was $1.0 million, 96.0% down from the prior year.
  • Other Working Capital Changes reached -$1.0 million in Q4 2025 per RCUS's latest filing, up from -$17.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $83.0 million in Q3 2024 and bottomed at -$339.6 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is -$34.2 million, with a median of -$17.5 million recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: tumbled 6683.92% in 2022, then soared 318.42% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$339.6 million in 2021, then surged by 64.08% to -$122.0 million in 2022, then soared by 86.07% to -$17.0 million in 2023, then soared by 588.24% to $83.0 million in 2024, then tumbled by 101.2% to -$1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$1.0 million in Q4 2025, -$17.0 million in Q1 2025, and $83.0 million in Q3 2024.